
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018. The Companys self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (TAVR) product approved by the National Medical Products Administration (NMPA) and commercialized in China
Venus medtech operates in the Medical equipment manufacturing industry.
Venus medtech's revenue is 11m - 100m
Venus medtech has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.